⌘K

Login Start Free

Home/Filings/4/0001104659-21-043486

4//SEC Filing

Giesing Dennis H 4

Accession 0001104659-21-043486

CIK 0001472012other

View on SEC.gov Company Profile

Filed

Mar 28, 8:00 PM ET

Accepted

Mar 29, 8:50 PM ET

Size

5.4 KB

Accession

0001104659-21-043486

Insider Transaction Report

Form 4

Period: 2021-03-25

Immunome Inc.IMNM

Giesing Dennis H

Chief Development Officer

Transactions

Award
Stock Option (Right to Buy)
2021-03-25+125,000→ 125,000 total
Exercise: $31.83Exp: 2031-03-24→ Common Stock (125,000 underlying)

Footnotes (1)

[F1]25% of the shares subject to the option shall vest on March 23, 2022, and the remaining 75% of shares subject to the option shall vest in equal monthly installments for the 36 months thereafter.

Documents

1 file

4
tm2111257-2_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Immunome Inc.

CIK 0001472012

Entity typeother

Related Parties

1

filerCIK 0001853622

Filing Metadata

Form type: 4
Filed: Mar 28, 8:00 PM ET
Accepted: Mar 29, 8:50 PM ET
Size: 5.4 KB

View on SEC.gov